DK4218753T3 - Ny lipasehæmmer og anvendelser deraf - Google Patents
Ny lipasehæmmer og anvendelser derafInfo
- Publication number
- DK4218753T3 DK4218753T3 DK22197886.9T DK22197886T DK4218753T3 DK 4218753 T3 DK4218753 T3 DK 4218753T3 DK 22197886 T DK22197886 T DK 22197886T DK 4218753 T3 DK4218753 T3 DK 4218753T3
- Authority
- DK
- Denmark
- Prior art keywords
- applications
- lipase inhibitor
- new lipase
- new
- inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
- C07D305/12—Beta-lactones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Epoxy Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762531454P | 2017-07-12 | 2017-07-12 | |
| EP18831486.8A EP3651784B1 (en) | 2017-07-12 | 2018-07-12 | Compounds for the reducing lipotoxic damage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK4218753T3 true DK4218753T3 (da) | 2026-03-09 |
Family
ID=65002124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK22197886.9T DK4218753T3 (da) | 2017-07-12 | 2018-07-12 | Ny lipasehæmmer og anvendelser deraf |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US11339126B2 (enExample) |
| EP (2) | EP3651784B1 (enExample) |
| JP (1) | JP7224331B2 (enExample) |
| KR (1) | KR102679975B1 (enExample) |
| CN (1) | CN111343999B (enExample) |
| AU (2) | AU2018300985B2 (enExample) |
| BR (1) | BR112020000635B1 (enExample) |
| CA (1) | CA3069526A1 (enExample) |
| DK (1) | DK4218753T3 (enExample) |
| ES (2) | ES2934883T3 (enExample) |
| IL (1) | IL271884B2 (enExample) |
| PL (2) | PL4218753T3 (enExample) |
| SG (1) | SG11202000239XA (enExample) |
| WO (1) | WO2019014434A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3651784B1 (en) | 2017-07-12 | 2022-09-28 | Mayo Foundation for Medical Education and Research | Compounds for the reducing lipotoxic damage |
| AU2022261098A1 (en) * | 2021-04-23 | 2023-10-26 | Panafina, Inc. | Methods of synthesizing lipstatin derivatives |
| CN114560887B (zh) * | 2022-02-15 | 2024-01-26 | 安徽美致诚药业有限公司 | 一种制备奥利司他的中间体的制备方法 |
| CA3246171A1 (en) * | 2022-03-31 | 2023-10-05 | Mayo Foundation For Medical Education And Research | METHODS AND MATERIALS FOR THE TREATMENT OF PANCREATIC DISEASES AND DISORDERS |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA859575B (en) * | 1984-12-21 | 1986-08-27 | Hoffmann La Roche | Oxetanones |
| CA1270837A (en) * | 1984-12-21 | 1990-06-26 | Hoffmann-La Roche Limited | Oxetanones |
| IL97148A (en) * | 1990-02-26 | 1996-11-14 | Hoffmann La Roche | Oxetanones a process for their manufacture and pharmaceutical compositions containing them |
| FR2754827B1 (fr) | 1996-10-17 | 1998-12-24 | Biocem | Lipases pancreatiques et/ou colipases recombinantes et polypeptides dervies produits par les plantes, leurs procedes d'obtention et leurs utilisations |
| FR2758143B1 (fr) | 1997-01-07 | 1999-02-19 | Laphal Laboratoire De Pharmaco | Inhibiteurs specifiques de la lipase pancreatique et leurs applications |
| US7060708B2 (en) | 1999-03-10 | 2006-06-13 | New River Pharmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
| US8980290B2 (en) | 2000-08-03 | 2015-03-17 | Antares Pharma Ipl Ag | Transdermal compositions for anticholinergic agents |
| US20040018197A1 (en) | 2002-04-26 | 2004-01-29 | Promega Corporation | Treatment for weight loss |
| DE102004009076A1 (de) | 2004-02-23 | 2005-10-27 | Solvay Pharmaceuticals Gmbh | Alkylcarbamat-substituierte β-Lactone, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| EP1803714A1 (en) | 2005-12-27 | 2007-07-04 | KRKA, tovarna zdravil, d.d., Novo mesto | Process for preparing crystalline forms of orlistat |
| US8258321B2 (en) * | 2007-10-31 | 2012-09-04 | Burnham Institute For Medical Research | Beta-lactone compounds |
| US9023887B2 (en) | 2011-04-15 | 2015-05-05 | University of Pittsburgh—of the Commonwealth System of Higher Education | Lipase inhibitors for the treatment of pancreatitis and organ failure |
| US20150099800A1 (en) * | 2012-05-24 | 2015-04-09 | Northeastern University | Novel lipase inhibitors, reporter substrates and uses thereof |
| CN106470804B (zh) | 2014-06-30 | 2019-09-10 | 工机控股株式会社 | 电动工具 |
| EA034983B1 (ru) | 2014-12-22 | 2020-04-14 | Университет Либре Де Брюссель | Композиция, содержащая ванкомицин и орлистат |
| WO2017079299A1 (en) | 2015-11-03 | 2017-05-11 | Mayo Foundation For Medical Education And Research | Using colipase inhibitors to treat pancreatitis |
| EP3651784B1 (en) | 2017-07-12 | 2022-09-28 | Mayo Foundation for Medical Education and Research | Compounds for the reducing lipotoxic damage |
-
2018
- 2018-07-12 EP EP18831486.8A patent/EP3651784B1/en active Active
- 2018-07-12 KR KR1020207003413A patent/KR102679975B1/ko active Active
- 2018-07-12 PL PL22197886.9T patent/PL4218753T3/pl unknown
- 2018-07-12 EP EP22197886.9A patent/EP4218753B1/en active Active
- 2018-07-12 DK DK22197886.9T patent/DK4218753T3/da active
- 2018-07-12 PL PL18831486.8T patent/PL3651784T3/pl unknown
- 2018-07-12 JP JP2020501125A patent/JP7224331B2/ja active Active
- 2018-07-12 AU AU2018300985A patent/AU2018300985B2/en active Active
- 2018-07-12 BR BR112020000635-1A patent/BR112020000635B1/pt active IP Right Grant
- 2018-07-12 US US16/629,842 patent/US11339126B2/en active Active
- 2018-07-12 ES ES18831486T patent/ES2934883T3/es active Active
- 2018-07-12 CA CA3069526A patent/CA3069526A1/en active Pending
- 2018-07-12 WO PCT/US2018/041796 patent/WO2019014434A1/en not_active Ceased
- 2018-07-12 ES ES22197886T patent/ES3064684T3/es active Active
- 2018-07-12 SG SG11202000239XA patent/SG11202000239XA/en unknown
- 2018-07-12 CN CN201880057761.7A patent/CN111343999B/zh active Active
-
2020
- 2020-01-07 IL IL271884A patent/IL271884B2/en unknown
-
2022
- 2022-04-20 US US17/725,281 patent/US11623915B2/en active Active
-
2023
- 2023-03-03 US US18/178,062 patent/US11976040B2/en active Active
-
2024
- 2024-04-17 US US18/637,793 patent/US12325690B2/en active Active
- 2024-12-11 AU AU2024278291A patent/AU2024278291A1/en active Pending
-
2025
- 2025-05-14 US US19/207,836 patent/US20250340512A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289612A (en) | Hpk1 inhibitors and uses thereof | |
| IL283106A (en) | Erk inhibitors and uses thereof | |
| EP3805217A4 (en) | ERK INHIBITOR AND ITS USE | |
| DK4480953T3 (da) | Tyk2-hæmmere og anvendelser deraf | |
| EP4003319A4 (en) | HDAC6 INHIBITORS AND USES THEREOF | |
| DK3658557T3 (da) | Tyk2-inhibitorer og anvendelser deraf | |
| IL282090A (en) | Tyk2 inhibitors and uses thereof | |
| DK3610005T3 (da) | Peptidligase og anvendelse deraf | |
| EP3670513A4 (en) | FGFR INHIBITOR AND MEDICAL APPLICATION OF IT | |
| DK3897833T3 (da) | Hæmmere af APOL1 og fremgangsmåder til anvendelse heraf | |
| DK3485010T3 (da) | Bacillus cibi-dnase-varianter og anvendelser deraf | |
| EP3746071A4 (en) | GCN2 INHIBITORS AND THEIR USES | |
| DK3668512T3 (da) | Pyruvatkinasemodulatorer og anvendelse deraf | |
| EP3572400C0 (en) | EZH2 INHIBITOR AND ITS USE | |
| DK3389658T3 (da) | Glycosidasehæmmere og anvendelser deraf | |
| DK3559227T3 (da) | Proteasevarianter og anvendelser deraf | |
| DK3710430T3 (da) | Acss2-inhibitorer og fremgangsmåder til anvendelse deraf | |
| EP3606519A4 (en) | ASK1 INHIBITOR COMPOUNDS AND ASSOCIATED USES | |
| DK3474883T3 (da) | Komplementinhibitorer og anvendelser deraf | |
| DK3621694T5 (da) | Lrrc33-inhibitorer og anvendelse heraf | |
| IL291217A (en) | Usp30 inhibitors and uses thereof | |
| DK3543240T3 (da) | URAT1-inhibitor og anvendelse deraf | |
| DK3490988T3 (da) | Ny forbindelse og fremgangsmåde | |
| DK3532459T3 (da) | Lsd1-hæmmere og medicinske anvendelser deraf | |
| EP3595665A4 (en) | DUAL MAGL AND FAAH INHIBITORS |